Combination of Radiofrequency Ablation with Antiangiogenic Therapy for Tumor Ablation Efficacy: Study in Mice

Antoine Hakimé, Andrew Hines-Peralta, Himaja Peddi, Michael B. Atkins, Vikas P. Sukhatme, Sabina Signoretti, Meredith M. Regan, S. Nahum Goldberg

Radiology · 2007 · 81 citations · 25 references

Abstract

Treatment of RCC in nude mice with the antiangiogenic agent sorafenib resulted in markedly decreased MVD and significantly larger zones of RF-induced coagulation necrosis.

References

25